| Dr Nabeel Kamal Shalan, MD | |
|
16659 Southwest Fwy Ste 131, Sugar Land, TX 77479-2351 | |
| (281) 276-5200 | |
| Not Available |
| Full Name | Dr Nabeel Kamal Shalan |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 26 Years |
| Location | 16659 Southwest Fwy Ste 131, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578597324 | NPI | - | NPPES |
| 8X9510 | Other | TX | BLUE CROSS BLUE SHIELD |
| 198233201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | L8504 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud music. Exposure to loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). In some people, a repeated TTS will ultimately give way to a PTS that is irreversible.
The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.
The AIDS 2012 Conference Coordinating Committee (CCC) have selected Turning The Tide Together as the theme for the XIX International AIDS Conference (AIDS 2012), which will be held in Washington, D.C. from 22 - 27 July 2012.
› Verified 8 days ago
| Entity Name | Oncology And Hematology Consultants Of Houston Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265696991 PECOS PAC ID: 6507926516 Enrollment ID: O20081120000683 |
News Archive
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud music. Exposure to loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). In some people, a repeated TTS will ultimately give way to a PTS that is irreversible.
The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.
The AIDS 2012 Conference Coordinating Committee (CCC) have selected Turning The Tide Together as the theme for the XIX International AIDS Conference (AIDS 2012), which will be held in Washington, D.C. from 22 - 27 July 2012.
› Verified 8 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud music. Exposure to loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). In some people, a repeated TTS will ultimately give way to a PTS that is irreversible.
The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.
The AIDS 2012 Conference Coordinating Committee (CCC) have selected Turning The Tide Together as the theme for the XIX International AIDS Conference (AIDS 2012), which will be held in Washington, D.C. from 22 - 27 July 2012.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nabeel Kamal Shalan, MD 5090 Richmond Ave # 494, Houston, TX 77056-7402 Ph: (832) 444-4901 | Dr Nabeel Kamal Shalan, MD 16659 Southwest Fwy Ste 131, Sugar Land, TX 77479-2351 Ph: (281) 276-5200 |
News Archive
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud music. Exposure to loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). In some people, a repeated TTS will ultimately give way to a PTS that is irreversible.
The finding represents a step forward in understanding the molecular events that govern the growth of this type of cancer and the changes in gene expression and cellular signaling that underlie resistance to established therapies.
The AIDS 2012 Conference Coordinating Committee (CCC) have selected Turning The Tide Together as the theme for the XIX International AIDS Conference (AIDS 2012), which will be held in Washington, D.C. from 22 - 27 July 2012.
› Verified 8 days ago
Vandana Khera, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393 | |
Susan Vijayan Mathew, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897 | |
Saif K Altaie, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Priya N. Oolut, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247 | |
Dr. Htut Kyaw Win, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963 | |
Cathlyn Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200 | |
Angela Denise Mcgee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100 |